T. Rowe Price Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.99M Buy
19,637
+2,712
+16% +$632K ﹤0.01% 647
2026
Q1
$4.14M Buy
16,925
+3,025
+22% +$705K ﹤0.01% 572
2025
Q4
$2.88M Buy
13,900
+6,364
+84% +$1.26M ﹤0.01% 602
2025
Q3
$1.4M Sell
7,536
-619,454
-99% -$106M ﹤0.01% 627
2025
Q2
$95.8M Buy
626,990
+9,166
+1% +$1.41M 0.06% 286
2025
Q1
$102M Buy
+617,824
New +$96.7M 0.07% 275
2024
Q3
Sell
-2,384
Closed -$349K 639
2024
Q2
$349K Hold
2,384
﹤0.01% 607
2024
Q1
$378K Buy
2,384
+556
+30% +$88.5K ﹤0.01% 594
2023
Q4
$287K Buy
+1,828
New +$280K ﹤0.01% 560

Other funds holding JNJ

T. Rowe Price Investment Management's JNJ Position: Q2 2026 in Review

T. Rowe Price Investment Management increased its Johnson & Johnson (JNJ) stake by 16% in Q2 2026, buying an estimated $632K and bringing the position to 19,637 shares worth $4.99M. The position accounts for ﹤0.01% of the portfolio, ranked #647.

T. Rowe Price Investment Management first reported a position in JNJ in Q4 2023 and has held it in 9 quarters since. The position peaked at $102M in Q1 2025. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • T. Rowe Price Investment Management held 19,637 shares of Johnson & Johnson worth $4.99M as of Q2 2026.
  • T. Rowe Price Investment Management bought 2,712 Johnson & Johnson shares in Q2 2026, an estimated $632K.
  • Johnson & Johnson made up ﹤0.01% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #647 holding.
  • T. Rowe Price Investment Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 9 quarters since.
  • T. Rowe Price Investment Management's Johnson & Johnson position peaked at $102M in Q1 2025.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.